© John Wiley & Sons Ltd
Editors-in-Chief: David Morgan, Thomas Permutt and Gerd Rosenkranz
Impact Factor: 1.235
ISI Journal Citation Reports © Ranking: 2015: 45/123 (Statistics & Probability); 208/253 (Pharmacology & Pharmacy)
Online ISSN: 1539-1612
Welcome to the new Editor-in-Chief
We are delighted to welcome David Morgan as one of three Editors-in-Chief of Pharmaceutical Statistics.
David Morgan is a seasoned drug development professional with experience in UK, US, German and French pharmaceutical companies. He has degrees in Mathematics and in Applied Statistics from Oxford University and is a Chartered Mathematician and Chartered Statistician. David was Chairman of PSI (Statisticians in the Pharmaceutical Industry) from 1995 to 1997 and President of EFSPI (European Federation of Statisticians in the Pharmaceutical Industry) from 2001 to 2003.
David joins existing editors Thomas Permutt and Gerd Rosenkranz in the role.
Recently Published Articles
- Generalized optimal design for two-arm, randomized phase II clinical trials with endpoints from the exponential dispersion family
Wei Jiang, Jonathan D. Mahnken, Jianghua He and Matthew S. Mayo
Version of Record online: 11 AUG 2016 | DOI: 10.1002/pst.1769